Rank,Term name,P-value,Z-score,Combined score,Overlapping genes,Adjusted p-value,Old p-value,Old adjusted p-value,gene count
1,Cytoplasmic Ribosomal Proteins WP477,1.5856245134146278e-70,101.53397612488521,16318.53842580579,"['RPL5', 'RPL30', 'RPL3', 'RPL32', 'RPL34', 'RPLP1', 'RPL10A', 'RPL8', 'RPL9', 'RPL6', 'RPL7', 'RPS4X', 'RPS15', 'RPL7A', 'RPS14', 'RPS17', 'RPS16', 'RPL18A', 'RPS19', 'RPS18', 'RPL36', 'RPL35', 'RPLP2', 'RPL38', 'RPL37', 'RPS11', 'RPL39', 'RPS10', 'RPS13', 'RPS12', 'RPS9', 'RPS7', 'RPL21', 'RPS8', 'RPL23', 'RPS5', 'RPS6', 'RPL22', 'RPL13A', 'RPSA', 'RPS3A', 'RPL37A', 'RPL24', 'RPL27', 'RPL26', 'RPL29', 'RPL28', 'UBA52', 'RPL10', 'RPL12', 'RPL11', 'RPL36A', 'RPS15A', 'RPL14', 'RPS3', 'RPL13', 'RPS2', 'RPL15', 'RPS27A', 'RPL18', 'RPL17', 'RPL19', 'RPL41', 'RPL35A', 'RPL23A', 'RPS26', 'RPS25', 'RPS28', 'RPS27', 'RPS29', 'RPL27A', 'RPS20', 'FAU', 'RPS21', 'RPS24', 'RPS23']",6.4376355244633884e-68,0,0,76
2,Electron Transport Chain (OXPHOS system in mitochondria) WP111,1.131056209685917e-50,45.91181418219462,5280.138819492162,"['COX7B', 'NDUFA12', 'COX4I1', 'COX6A1', 'COX7C', 'ATP5IF1', 'UQCRFS1', 'COX8A', 'NDUFC2', 'NDUFC1', 'COX6B1', 'NDUFS6', 'NDUFS5', 'NDUFS3', 'SLC25A5', 'SLC25A4', 'SLC25A6', 'NDUFB9', 'NDUFB8', 'NDUFB7', 'UQCRB', 'NDUFB10', 'NDUFB6', 'NDUFB5', 'NDUFB4', 'COX17', 'NDUFB3', 'ATP5MC2', 'NDUFB2', 'ATP5MC3', 'NDUFB1', 'COX7A2', 'UQCR11', 'UQCR10', 'COX5B', 'COX7A1', 'COX5A', 'UQCRH', 'ATP5MC1', 'COX11', 'NDUFV2', 'ATP5MG', 'ATP5MF', 'ATP5ME', 'ATP5PF', 'NDUFA8', 'NDUFA7', 'ATP5PD', 'NDUFA6', 'NDUFA5', 'ATP5PB', 'NDUFA4', 'NDUFA2', 'NDUFA1', 'COX6C', 'ATP5F1C', 'ATP5F1D', 'ATP5F1E', 'UQCRQ', 'NDUFAB1', 'ATP5PO']",2.2960441056624116e-48,0,0,61
3,Oxidative phosphorylation WP623,1.1113272643978318e-27,32.76427996781979,2033.4902164790158,"['NDUFB9', 'NDUFB8', 'NDUFB7', 'NDUFA11', 'NDUFB10', 'NDUFB6', 'NDUFB5', 'NDUFB4', 'ATP5MC2', 'NDUFB2', 'ATP5MC3', 'NDUFB1', 'ATP5MC1', 'NDUFV2', 'ATP5MG', 'ATP5MF', 'ATP5ME', 'ATP5PF', 'NDUFA8', 'NDUFA7', 'NDUFA6', 'ATP5PD', 'NDUFA5', 'ATP5PB', 'NDUFA4', 'NDUFA2', 'NDUFC2', 'NDUFC1', 'ATP5F1D', 'ATP5F1E', 'NDUFS6', 'NDUFS5', 'NDUFAB1', 'NDUFS3', 'ATP5PO']",1.5039962311517325e-25,0,0,35
4,Nonalcoholic fatty liver disease WP4396,2.095301634011588e-25,9.47584316491408,538.4641226779886,"['NDUFA13', 'COX7B', 'NDUFA11', 'NDUFA12', 'COX4I1', 'COX6A1', 'COX7C', 'UQCRFS1', 'COX8A', 'NDUFC2', 'NDUFC1', 'COX6B1', 'NDUFS6', 'DDIT3', 'NDUFS5', 'NDUFS3', 'NDUFB9', 'NDUFB8', 'NDUFB7', 'UQCRB', 'NDUFB10', 'NDUFB6', 'NDUFB11', 'NDUFB5', 'NDUFB4', 'NDUFB3', 'NDUFB2', 'NDUFB1', 'COX7A2', 'UQCR11', 'UQCR10', 'COX5B', 'COX7A1', 'COX5A', 'UQCRH', 'CYC1', 'NDUFV2', 'NDUFA8', 'XBP1', 'NDUFA7', 'NDUFA6', 'NDUFA5', 'NDUFA4', 'NDUFA2', 'NDUFA1', 'COX6C', 'EIF2S1', 'UQCRQ', 'NDUFAB1', 'CYCS', 'BAX']",2.1267311585217618e-23,0,0,51
5,Mitochondrial complex I assembly model OXPHOS system WP4324,1.412380435301548e-23,30.758590308370046,1618.3380256699745,"['NDUFB9', 'NDUFA13', 'NDUFB8', 'NDUFB7', 'DMAC1', 'NDUFB10', 'NDUFB6', 'NDUFA12', 'NDUFB11', 'NDUFB5', 'NDUFB4', 'NDUFB3', 'NDUFB2', 'NDUFB1', 'NDUFV2', 'NDUFA8', 'NDUFA7', 'NDUFA6', 'NDUFA5', 'NDUFA2', 'NDUFA1', 'NDUFC2', 'NDUFC1', 'NDUFS6', 'NDUFS5', 'NDUFAF4', 'NDUFAB1', 'NDUFS3', 'NDUFAF3', 'TMEM126B']",1.1468529134648569e-21,0,0,30
6,Mitochondrial CIV Assembly WP4922,5.77782059642238e-15,22.587093643862204,740.5122147893258,"['COX8A', 'COA3', 'COX7B', 'COX16', 'PET100', 'NDUFA4', 'TACO1', 'COX4I1', 'COX17', 'COX7A2', 'COX6A1', 'COX5B', 'COX6C', 'COX5A', 'COX7C', 'PET117', 'COX6B1', 'COX11', 'COX14', 'SMIM20']",3.909658603579144e-13,0,0,20
7,Mitochondrial complex III assembly WP4921,7.049918487541848e-08,30.217993079584776,497.61977761655305,"['UQCRB', 'UQCC3', 'UQCRQ', 'LYRM7', 'UQCRFS1', 'UQCR11', 'UQCR10', 'CYC1', 'UQCRH']",4.088952722774272e-06,0,0,9
8,Cellular Proteostasis WP4918,5.586232203023761e-07,inf,inf,"['VBP1', 'PFDN1', 'PFDN2', 'PFDN4', 'PFDN5', 'PFDN6']",2.835012843034559e-05,0,0,6
9,Proteasome Degradation WP183,7.420506152372135e-05,4.369820601851852,41.551217875128,"['H2AFZ', 'HLA-B', 'PSMB10', 'PSMA7', 'PSMD8', 'PSMB6', 'PSMC5', 'PSMD7', 'PSMB5', 'PSMD4', 'PSMA2', 'PSMB1', 'PSME1']",0.00334747277540343,0,0,13
10,mRNA Processing WP411,0.00011832148729928921,3.436846101142529,31.07632389790988,"['SF3B5', 'DHX8', 'RNMT', 'SNU13', 'LSM2', 'PRPF4', 'LSM7', 'PHF5A', 'SNRPD1', 'SNRPG', 'SRSF3', 'SNRPE', 'SNRPB2', 'DNAJC8', 'HNRNPA1', 'SRSF9']",0.004803852384351142,0,0,16
11,Hijack of ubiquitination by SARS-CoV-2 WP4860,0.00031554584813540444,40.12403100775194,323.4481022770568,"['UBA3', 'ELOB', 'ELOC', 'RBX1']",0.010781836957250768,0,0,4
12,Cholesterol Biosynthesis Pathway WP197,0.00031867498395815076,10.04400345125108,80.86767503221681,"['IDI1', 'SQLE', 'NSDHL', 'HMGCS1', 'PMVK', 'FDFT1']",0.010781836957250768,0,0,6
13,Pyrimidine metabolism WP4022,0.0009363123823787518,3.0020148991626154,20.934735208941255,"['POLR3GL', 'NME2', 'NME1', 'POLE4', 'POLD4', 'POLD2', 'POLE3', 'POLR3H', 'POLR2I', 'DCTPP1', 'POLR2J', 'POLR3K', 'POLR2K', 'POLR2L']",0.029241755941982556,0,0,14
14,Base Excision Repair WP4752,0.00253555357813695,4.68762233736327,28.01952793254551,"['POLE4', 'POLD4', 'NEIL2', 'TDG', 'APEX1', 'POLD2', 'POLE3']",0.07353105376597155,0,0,7
15,VEGFA-VEGFR2 Signaling Pathway WP3888,0.003529392638950246,1.649420295995029,9.313665267937779,"['RPL5', 'SET', 'NOTCH4', 'CLTC', 'ARPC5L', 'TXN', 'RPL10A', 'RPL7', 'ICAM1', 'ACTG1', 'LDHA', 'PAK1', 'PSMD4', 'RPL18A', 'CCND1', 'TMSB4X', 'RACK1', 'AP2S1', 'PGK1', 'RPLP2', 'ELOC', 'ATP6V1E1', 'RPS11', 'CCT7', 'TMSB10', 'ACP1', 'HRAS', 'SLC25A25', 'PTPN1', 'SDF2L1', 'SSR4', 'TPM3', 'RPS6', 'SARS', 'RPL13A', 'TFCP2', 'PTPN9', 'CYCS', 'RPL27', 'RPL26', 'PTMA']",0.09552889409425333,0,0,41
16,Selenium Micronutrient Network WP15,0.004542717133721393,2.6833188782885227,14.474439081062904,"['SERPINA3', 'SELENOM', 'PRDX5', 'GPX4', 'PRDX1', 'SELENOW', 'TXN', 'SEPHS2', 'ICAM1', 'SELENOH', 'SOD1', 'MSRB1']",0.11527144726818035,0,0,12
17,Nucleotide Excision Repair WP4753,0.005391369604978554,3.494494757806922,18.25159175152426,"['POLE4', 'POLD4', 'POLD2', 'POLE3', 'RPA2', 'RAD23A', 'GTF2H5', 'RBX1']",0.128758591742429,0,0,8
18,Fatty acid transporters WP5061,0.005899247186164408,8.022049956933678,41.17662515138384,"['FABP3', 'FABP5', 'FABP6', 'DBI']",0.13229653734134608,0,0,4
19,Dual hijack model of Vif in HIV infection WP3300,0.006517070804992418,15.032271944922547,75.66238936261094,"['ELOB', 'ELOC', 'RBX1']",0.13229653734134608,0,0,3
20,Mevalonate pathway WP3963,0.006517070804992418,15.032271944922547,75.66238936261094,"['HMGCS1', 'PMVK', 'ACAT2']",0.13229653734134608,0,0,3
21,nsp1 from SARS-CoV-2 inhibits translation initiation in the host cell WP5027,0.008524046928562077,5.015948275862069,23.900311662955218,"['EIF5', 'EIF3I', 'EIF3J', 'EIF2S1', 'EIF1']",0.1647982406188668,0,0,5
22,Computational Model of Aerobic Glycolysis WP4629,0.009130876828200393,6.684467413149584,31.39088430974923,"['LDHA', 'TPI1', 'PGK1', 'PFKM']",0.16850618146587998,0,0,4
23,Glycolysis and Gluconeogenesis WP534,0.009726448912000807,3.0904860049198857,14.317932428991467,"['LDHA', 'TPI1', 'PDHA1', 'GOT1', 'MPC2', 'PGK1', 'DLD', 'PFKM']",0.17169296775097076,0,0,8
24,DNA Mismatch Repair WP531,0.011485655759932687,4.559561128526646,20.3659926560634,"['POLE4', 'POLD4', 'POLD2', 'POLE3', 'RPA2']",0.19429900993886132,0,0,5
25,Ciliary landscape WP4352,0.012513661677625212,1.7886292439251545,7.835867199832643,"['POM121', 'NUDC', 'NDUFA5', 'TRAF3IP1', 'SSNA1', 'COPS7A', 'MYL6B', 'DYNLL1', 'COX6C', 'LSM4', 'PSMD8', 'COPS4', 'MYL6', 'COPS6', 'IFT22', 'PSMD7', 'RAB14', 'RANBP10', 'NEFL', 'SNRPB2', 'DCAF11', 'CALM2']",0.20322186564463343,0,0,22
26,7q11.23 copy number variation syndrome WP4932,0.018600355034817263,2.154194028001487,8.583546830176934,"['ATP5PB', 'CLTC', 'ATP5MC2', 'EIF4H', 'ATP5PO', 'ATP5MC3', 'SQSTM1', 'DLD', 'ATP5F1D', 'VAMP2', 'ATP5F1E', 'ATP5MC1']",0.2861731205541154,0,0,12
27,Mechanoregulation and pathology of YAP/TAZ via Hippo and non-Hippo mechanisms WP4534,0.01903121737675152,2.9274971214738055,11.597791070467792,"['MAP4K1', 'LATS1', 'PAK1', 'YWHAQ', 'LIMD1', 'ACTG1', 'PAK4']",0.2861731205541154,0,0,7
28,Mevalonate arm of cholesterol biosynthesis pathway WP4190,0.01984677758598865,7.514845094664372,29.456040694278816,"['IDI1', 'HMGCS1', 'PMVK']",0.2877782749968354,0,0,3
29,Aflatoxin B1 metabolism WP699,0.02328530372104929,20.027515047291487,75.30211191037827,"['AKR7A2', 'AKR7A3']",0.3259942520946901,0,0,2
30,Eukaryotic Transcription Initiation WP405,0.031357367859672115,2.866017502773327,9.92302965347428,"['GTF2A2', 'POLR3H', 'POLR2I', 'POLR2J', 'POLR3K', 'POLR2K']",0.40872166104969865,0,0,6
31,Ferroptosis WP4313,0.031357367859672115,2.866017502773327,9.92302965347428,"['MAP1LC3B', 'MAP1LC3A', 'GPX4', 'FTH1', 'VDAC2', 'FTL']",0.40872166104969865,0,0,6
32,Unfolded protein response WP4925,0.03246305945369665,4.0093023255813955,13.742495012426643,"['XBP1', 'DDIT3', 'TNFRSF10B', 'EIF2S1']",0.40872166104969865,0,0,4
33,Translation Factors WP107,0.03322121875527107,2.3616859016726828,8.040516676193246,"['EEF1B2', 'EIF5', 'EIF1AY', 'EIF3I', 'EIF3J', 'EIF4H', 'EIF2S1', 'EIF1']",0.40872166104969865,0,0,8
34,Cytosolic DNA-sensing pathway WP4655,0.03548327741402065,2.508419689119171,8.374845144067462,"['IRF3', 'POLR3GL', 'POLR3H', 'IKBKG', 'POLR3K', 'POLR2K', 'POLR2L']",0.42371207735565836,0,0,7
35,Melanoma WP4685,0.038608022820207276,2.1511987147800298,7.000635606633553,"['PAK1', 'CCND1', 'BAD', 'GADD45A', 'BAX', 'KRAS', 'CALM3', 'HRAS', 'CALM2']",0.4478530647144044,0,0,9
36,Cholesterol metabolism (includes both Bloch and Kandutsch-Russell pathways) WP4718,0.0573316758176602,2.4066264020707506,6.880309037530524,"['IDI1', 'SQLE', 'NSDHL', 'HMGCS1', 'PMVK', 'FDFT1']",0.6252120147689664,0,0,6
37,Synaptic Vesicle Pathway WP2267,0.059332103152897,2.194111614853195,6.197498091431635,"['RAB3A', 'CLTC', 'AP2S1', 'PARK7', 'SLC25A4', 'AP2M1', 'VAMP2']",0.6252120147689664,0,0,7
38,DNA damage response WP707,0.05947152778661773,2.0580191919863484,5.808260316960897,"['CCNB1', 'CCND1', 'GADD45A', 'SESN1', 'RPA2', 'TNFRSF10B', 'CYCS', 'BAX']",0.6252120147689664,0,0,8
39,CAMKK2  Pathway WP4874,0.0611065146909364,2.6379310344827585,7.37337809733687,"['FIS1', 'MAP1LC3A', 'SQSTM1', 'CALM2', 'ICAM1']",0.6252120147689664,0,0,5
40,DNA Repair Pathways Full Network WP4946,0.06159724283438092,1.7463705267921112,4.867375951786683,"['POLE4', 'POLD4', 'NEIL2', 'CENPX', 'TDG', 'APEX1', 'POLD2', 'POLE3', 'RPA2', 'RAD23A', 'GTF2H5', 'RBX1']",0.6252120147689664,0,0,12
41,Peroxiredoxin 2 induced ovarian failure WP4873,0.06861284196974304,6.67469188879335,17.883338855149645,"['STAR', 'BAX']",0.6570703179003674,0,0,2
42,Hereditary leiomyomatosis and renal cell carcinoma pathway WP4206,0.07115011831612254,3.756131669535284,9.9273181207598,"['LDHA', 'PDHA1', 'RPS6']",0.6570703179003674,0,0,3
43,RalA downstream regulated genes WP2290,0.07115011831612254,3.756131669535284,9.9273181207598,"['RAC3', 'KRAS', 'HRAS']",0.6570703179003674,0,0,3
44,Leptin signaling pathway WP2034,0.07282799090028703,1.957290722431857,5.127426246008724,"['PTPN1', 'CCND1', 'BAD', 'CFL2', 'RPS6', 'BAX', 'IKBKG', 'HRAS']",0.6570703179003674,0,0,8
45,miRNA regulation of DNA damage response WP1530,0.07282799090028703,1.957290722431857,5.127426246008724,"['CCNB1', 'CCND1', 'GADD45A', 'SESN1', 'RPA2', 'TNFRSF10B', 'CYCS', 'BAX']",0.6570703179003674,0,0,8
46,Amyotrophic lateral sclerosis (ALS) WP2447,0.08151408447557543,2.386288998357964,5.982377499770587,"['BAD', 'NEFL', 'BAX', 'NEFH', 'SOD1']",0.7046873449131669,0,0,5
47,Copper homeostasis WP3286,0.08331278954638426,2.1482189079255516,5.338653105412804,"['CCND1', 'COX17', 'COX11', 'MT3', 'ATOX1', 'SOD1']",0.7046873449131669,0,0,6
48,Endoplasmic reticulum stress response in coronavirus infection WP4861,0.08331278954638426,2.1482189079255516,5.338653105412804,"['XBP1', 'MAP1LC3A', 'PPP1R11', 'PPP1R7', 'DDIT3', 'EIF2S1']",0.7046873449131669,0,0,6
49,Cori Cycle WP1946,0.08867434511260272,3.338496844520941,8.088458954394714,"['LDHA', 'TPI1', 'PGK1']",0.7126654271289221,0,0,3
50,TP53 network WP1742,0.08867434511260272,3.338496844520941,8.088458954394714,"['SUMO1', 'GADD45A', 'BAX']",0.7126654271289221,0,0,3
51,Mitochondrial CII Assembly WP4920,0.0909301285114194,inf,inf,['SDHAF1'],0.7126654271289221,0,0,1
52,Androgen receptor signaling pathway WP138,0.09127734534656146,1.7702015062080196,4.23760157796805,"['CCND1', 'SUMO1', 'PRDX1', 'BAG1', 'RACK1', 'DSTN', 'STUB1', 'PARK7', 'RAN']",0.7126654271289221,0,0,9
53,Arachidonate Epoxygenase / Epoxide Hydrolase WP678,0.09684132084767635,5.005588993981084,11.686456058497399,"['COX8A', 'COX5A']",0.7281032641510481,0,0,2
54,TCA cycle in senescence WP5050,0.09684132084767635,5.005588993981084,11.686456058497399,"['PDHA1', 'GOT1']",0.7281032641510481,0,0,2
55,Hippo-Yap signaling pathway WP4537,0.1077943773068904,3.0043889845094665,6.692365934992829,"['MAP4K1', 'LATS1', 'YWHAQ']",0.7815092354749554,0,0,3
56,Nanomaterial induced apoptosis WP2507,0.1077943773068904,3.0043889845094665,6.692365934992829,"['ENDOG', 'BAX', 'CYCS']",0.7815092354749554,0,0,3
57,T-Cell antigen Receptor (TCR) pathway during Staphylococcus aureus infection WP3863,0.11479144643452843,1.939825767485875,4.199021163813952,"['PAK1', 'PTPRC', 'RRAS', 'CHP1', 'IKBKG', 'CALM2']",0.8176373202178692,0,0,6
58,Trans-sulfuration pathway WP2333,0.12763916196988392,4.004127257093723,8.242688329692388,"['AHCY', 'GOT1']",0.8934741337891875,0,0,2
59,Inhibition of exosome biogenesis and secretion by Manumycin A in CRPC cells WP4301,0.15013208494125377,2.5032271944922546,4.746719049862913,"['RRAS', 'KRAS', 'HRAS']",0.9997174930961258,0,0,3
60,Glycolysis in senescence WP5049,0.16030660761928064,3.336486099168816,6.107994997319325,"['LDHA', 'PGK1']",0.9997174930961258,0,0,2
61,HIF1A and PPARG regulation of glycolysis WP2456,0.16030660761928064,3.336486099168816,6.107994997319325,"['LDHA', 'TPI1']",0.9997174930961258,0,0,2
62,Senescence and Autophagy in Cancer WP615,0.1619903403470327,1.5291185267726233,2.7833299427728555,"['GABARAPL2', 'GABARAPL1', 'MAP1LC3B', 'RNASEL', 'MAP1LC3A', 'SQSTM1', 'ING1', 'HRAS', 'GABARAP']",0.9997174930961258,0,0,9
63,MET in type 1 papillary renal cell carcinoma WP4205,0.16460028682458802,1.7175397510168864,3.0988457589443676,"['PAK1', 'BAD', 'RPL11', 'KRAS', 'HRAS', 'PAK4']",0.9997174930961258,0,0,6
64,Non-small cell lung cancer WP4255,0.16527972170834757,1.6312808772141223,2.936494738027327,"['CCND1', 'BAD', 'GADD45A', 'CYCS', 'BAX', 'KRAS', 'HRAS']",0.9997174930961258,0,0,7
65,Imatinib and Chronic Myeloid Leukemia WP3640,0.17299433886850077,2.3104726598702503,4.053715983271399,"['BCR', 'SPRED2', 'GADD45A']",0.9997174930961258,0,0,3
66,Methionine De Novo and Salvage Pathway WP3580,0.17299433886850077,2.3104726598702503,4.053715983271399,"['AHCY', 'ODC1', 'TXN']",0.9997174930961258,0,0,3
67,GABA metabolism (aka GHB) WP4157,0.17359852837181938,10.005154639175258,17.51912536363145,['AKR7A2'],0.9997174930961258,0,0,1
68,EGFR Tyrosine Kinase Inhibitor Resistance WP4806,0.17538631581724112,1.5417857855195798,2.6838855289386885,"['SHC3', 'CCND1', 'RRAS', 'BAD', 'RPS6', 'BAX', 'KRAS', 'HRAS']",0.9997174930961258,0,0,8
69,Chromosomal and microsatellite instability in colorectal cancer  WP4216,0.17759640612726932,1.5940689276181503,2.754936368514411,"['CCND1', 'BAD', 'GADD45A', 'RAC3', 'CYCS', 'BAX', 'KRAS']",0.9997174930961258,0,0,7
70,Association Between Physico-Chemical Features and Toxicity Associated Pathways WP3680,0.17829534747118023,1.669686511360368,2.8790635738208223,"['PAK1', 'TMSB4X', 'NEFL', 'NEFH', 'PFN2', 'SOD1']",0.9997174930961258,0,0,6
71,miRNA regulation of prostate cancer signaling pathways WP3981,0.18773963579243563,1.9073868996349617,3.1904845259125296,"['CCND1', 'BAD', 'KRAS', 'IKBKG']",0.9997174930961258,0,0,4
72,Pancreatic adenocarcinoma pathway WP4263,0.19377706148614265,1.454752204487108,2.387316665728654,"['PAK1', 'CCND1', 'BAD', 'GADD45A', 'RAC3', 'BAX', 'KRAS', 'IKBKG', 'PAK4']",0.9997174930961258,0,0,9
73,TCA Cycle (aka Krebs or citric acid cycle) WP78,0.19424973210805396,2.859599557793883,4.685770344023924,"['IDH3B', 'DLD']",0.9997174930961258,0,0,2
74,TCA Cycle and Deficiency of Pyruvate Dehydrogenase complex (PDHc) WP2453,0.19424973210805396,2.859599557793883,4.685770344023924,"['PDHA1', 'DLD']",0.9997174930961258,0,0,2
75,GABA receptor Signaling WP4159,0.19674993155206089,2.1452544873371036,3.4878013824391503,"['GABRB3', 'AP2S1', 'AP2M1']",0.9997174930961258,0,0,3
76,Photodynamic therapy-induced unfolded protein response WP3613,0.19674993155206089,2.1452544873371036,3.4878013824391503,"['NARS', 'XBP1', 'DDIT3']",0.9997174930961258,0,0,3
77,SARS-CoV-2 mitochondrial interactions WP5038,0.19674993155206089,2.1452544873371036,3.4878013824391503,"['NDUFB9', 'IRF3', 'PHB']",0.9997174930961258,0,0,3
78,Statin inhibition of cholesterol production WP430,0.19674993155206089,2.1452544873371036,3.4878013824391503,"['SQLE', 'APOC1', 'FDFT1']",0.9997174930961258,0,0,3
79,G Protein Signaling Pathways WP35,0.1987871020197478,1.4844265181343832,2.3981220141502795,"['GNG3', 'PDE1C', 'RRAS', 'PRKAR1A', 'GNA12', 'KRAS', 'HRAS', 'CALM2']",0.9997174930961258,0,0,8
80,Pathogenic Escherichia coli infection WP2272,0.20697305097761895,1.5815358067299397,2.4911825102674716,"['TUBA1A', 'YWHAQ', 'ARPC2', 'ARPC3', 'ARPC5L', 'ACTG1']",0.9997174930961258,0,0,6
81,Fas ligand pathway and stress induction of heat shock proteins WP314,0.20705337518775901,1.8205308902983321,2.8669332101238014,"['PAK1', 'ARHGDIB', 'CYCS', 'ACTG1']",0.9997174930961258,0,0,4
82,Photodynamic therapy-induced HIF-1 survival signaling WP3614,0.20705337518775901,1.8205308902983321,2.8669332101238014,"['LDHA', 'PDHA1', 'PGK1', 'BAX']",0.9997174930961258,0,0,4
83,Myometrial relaxation and contraction pathways WP289,0.22474046032348344,1.3216549278995073,1.9729784403264274,"['RGS4', 'CNN1', 'GNG3', 'YWHAQ', 'PRKAR1A', 'GSTO1', 'CRH', 'CALM3', 'IGFBP6', 'CALM2', 'ACTG1', 'YWHAH']",0.9997174930961258,0,0,12
84,Folate Metabolism WP176,0.2257952422640458,1.6151279199110122,2.4035149784082983,"['SERPINA3', 'AHCY', 'GPX4', 'ICAM1', 'SOD1']",0.9997174930961258,0,0,5
85,Galanin receptor pathway WP4970,0.22896700643687404,2.501934651762683,3.68829542608991,"['POMC', 'VAMP2']",0.9997174930961258,0,0,2
86,Homologous recombination WP186,0.22896700643687404,2.501934651762683,3.68829542608991,"['POLD4', 'POLD2']",0.9997174930961258,0,0,2
87,MAPK and NFkB signaling pathways inhibited by Yersinia YopJ WP3849,0.22896700643687404,2.501934651762683,3.68829542608991,"['RRAS', 'IKBKG']",0.9997174930961258,0,0,2
88,Pathways of nucleic acid metabolism and innate immune sensing WP4705,0.22896700643687404,2.501934651762683,3.68829542608991,"['RNASEL', 'IRF3']",0.9997174930961258,0,0,2
89,Integrated breast cancer pathway WP1984,0.23329209879888868,1.3280574638241005,1.9329397855737789,"['PAK1', 'CCND1', 'RRAS', 'GADD45A', 'BAD', 'ODC1', 'BAX', 'KRAS', 'PHB', 'FAU', 'CCNB1IP1']",0.9997174930961258,0,0,11
90,RAC1/PAK1/p38/MMP2 Pathway WP3303,0.2371502449737511,1.502200172562554,2.161758273896708,"['PAK1', 'BAD', 'BAX', 'KRAS', 'IKBKG', 'HRAS']",0.9997174930961258,0,0,6
91,Canonical and non-canonical Notch signaling WP3845,0.2462644947619023,1.8767749569707401,2.630016969456466,"['RRAS', 'NOTCH4', 'DLL3']",0.9997174930961258,0,0,3
92,Bladder cancer WP2828,0.247207629361262,1.6685328739592304,2.331819225773448,"['CCND1', 'DAPK1', 'KRAS', 'HRAS']",0.9997174930961258,0,0,4
93,Metabolic reprogramming in colon cancer WP4290,0.247207629361262,1.6685328739592304,2.331819225773448,"['LDHA', 'PDHA1', 'PGK1', 'PYCR2']",0.9997174930961258,0,0,4
94,Gastric acid production WP2596,0.24875516151634477,5.0021477663230245,6.959418924267133,['CCK'],0.9997174930961258,0,0,1
95,miRNA Biogenesis WP2338,0.24875516151634477,5.0021477663230245,6.959418924267133,['RAN'],0.9997174930961258,0,0,1
96,SARS-CoV-2 and angiotensin-converting enzyme 2 receptor: molecular mechanisms WP4883,0.24875516151634477,5.0021477663230245,6.959418924267133,['MAS1'],0.9997174930961258,0,0,1
97,The alternative pathway of fetal androgen synthesis WP4524,0.24875516151634477,5.0021477663230245,6.959418924267133,['STAR'],0.9997174930961258,0,0,1
98,Parkin-Ubiquitin Proteasomal System pathway WP2359,0.25271602130937015,1.4654348786801068,2.01568935959823,"['PSMD8', 'PSMC5', 'TUBA1A', 'PSMD7', 'PSMD4', 'STUB1']",0.9997174930961258,0,0,6
99,Modulators of TCR signaling and T cell activation WP5072,0.2608204699728155,1.516980146290491,2.0387044527876212,"['MAP4K1', 'NDUFB10', 'ELOB', 'IKBKG', 'RNF7']",0.9997174930961258,0,0,5
100,Cysteine and methionine catabolism WP4504,0.2640374282079182,2.2237508359606384,2.9612898502265845,"['AHCY', 'GOT1']",0.9997174930961258,0,0,2
101,PPAR-alpha pathway WP2878,0.2640374282079182,2.2237508359606384,2.9612898502265845,"['CCND1', 'DBI']",0.9997174930961258,0,0,2
102,Endometrial cancer WP4155,0.2685533204948494,1.4304203130777764,1.8805818794319744,"['CCND1', 'BAD', 'GADD45A', 'BAX', 'KRAS', 'HRAS']",0.9997174930961258,0,0,6
103,ErbB signaling pathway WP673,0.2730238200846775,1.3744454603948661,1.7842999212735646,"['PAK1', 'SHC3', 'CCND1', 'BAD', 'KRAS', 'HRAS', 'PAK4']",0.9997174930961258,0,0,7
104,Apoptosis-related network due to altered Notch3 in ovarian cancer WP2864,0.2787869744009218,1.47223630831643,1.8804982154632721,"['BEX3', 'SERBP1', 'TNFRSF10B', 'RNF7', 'SQSTM1']",0.9997174930961258,0,0,5
105,Notch Signaling Pathway Netpath WP61,0.2787869744009218,1.47223630831643,1.8804982154632721,"['PSENEN', 'CCND1', 'NOTCH4', 'SKP1', 'DLL3']",0.9997174930961258,0,0,5
106,Ras signaling WP4223,0.295200923735221,1.21706256490135,1.4849368878390765,"['SHC3', 'RASA4B', 'BAD', 'GNG3', 'PAK1', 'RRAS', 'RAC3', 'CALM3', 'KRAS', 'IKBKG', 'CALM2', 'HRAS', 'PAK4']",0.9997174930961258,0,0,13
107,p53 transcriptional gene network WP4963,0.2969886630782077,1.4300492610837439,1.7361674826533982,"['SIVA1', 'GADD45A', 'SESN1', 'BAX', 'ICAM1']",0.9997174930961258,0,0,5
108,Mammary gland development pathway - Pregnancy and lactation (Stage 3 of 4) WP2817,0.29740440058966217,1.6679575444635686,2.0226694793524973,"['PTPN1', 'CCND1', 'TPM3']",0.9997174930961258,0,0,3
109,PI3K-AKT-mTOR signaling pathway and therapeutic opportunities WP3844,0.29740440058966217,1.6679575444635686,2.0226694793524973,"['BAD', 'KRAS', 'HRAS']",0.9997174930961258,0,0,3
110,Host-pathogen interaction of human coronaviruses - apoptosis WP4864,0.29911004336676356,2.0012037833190024,2.4153403693053046,"['BAD', 'BAX']",0.9997174930961258,0,0,2
111,Alzheimer's disease WP2059,0.30250781799608434,1.3223514843419037,1.5810671154638216,"['PSENEN', 'ATP5MD', 'BAD', 'CHP1', 'CYCS', 'CALM3', 'CALM2']",0.9997174930961258,0,0,7
112,NO/cGMP/PKG mediated Neuroprotection WP4008,0.3100287223801621,1.482757520655884,1.7364429985574996,"['BAD', 'NEFL', 'CYCS', 'CALM2']",0.9997174930961258,0,0,4
113,Regulation of Actin Cytoskeleton WP51,0.31067570836547187,1.2240227228962064,1.4308894778239756,"['PAK1', 'RRAS', 'CFL2', 'TMSB4X', 'GNA12', 'BRK1', 'RAC3', 'KRAS', 'ACTG1', 'SSH1', 'PAK4']",0.9997174930961258,0,0,11
114,Glucuronidation WP698,0.3170820447568187,3.334478808705613,3.8299647613819587,['UGP2'],0.9997174930961258,0,0,1
115,MED and Pseudoachondroplasia genes WP4789,0.3170820447568187,3.334478808705613,3.8299647613819587,['COL9A3'],0.9997174930961258,0,0,1
116,Glycosylation and related congenital defects WP4521,0.3232286272624775,1.5800344234079173,1.7844835808929043,"['DPM2', 'DPM3', 'MAGT1']",0.9997174930961258,0,0,3
117,Hippo-Merlin Signaling Dysregulation WP4541,0.3280020108349662,1.2343698156135943,1.375995902995341,"['LATS1', 'PAK1', 'CCND1', 'PRKAR1A', 'KRAS', 'ITGAE', 'HRAS', 'RBX1', 'PAK4']",0.9997174930961258,0,0,9
118,Aryl Hydrocarbon Receptor Netpath WP2586,0.33134773216122165,1.4296788482834994,1.5792045337560916,"['KLF6', 'AIP', 'KRAS', 'HRAS']",0.9997174930961258,0,0,4
119,DNA Replication WP466,0.33134773216122165,1.4296788482834994,1.5792045337560916,"['POLD4', 'POLD2', 'RPA2', 'UBA52']",0.9997174930961258,0,0,4
120,Extracellular vesicles in the crosstalk of cardiac cells WP4300,0.3338947053514616,1.8191198311576644,1.9954463690009112,"['CD63', 'SOD1']",0.9997174930961258,0,0,2
121,PI3K/AKT/mTOR - VitD3 signaling WP4141,0.3338947053514616,1.8191198311576644,1.9954463690009112,"['LDHA', 'PDHA1']",0.9997174930961258,0,0,2
122,Serotonin Receptor 2 and ELK-SRF/GATA4 signaling WP732,0.3338947053514616,1.8191198311576644,1.9954463690009112,"['KRAS', 'HRAS']",0.9997174930961258,0,0,2
123,Brain-derived neurotrophic factor (BDNF) signaling pathway WP2380,0.33753294312980414,1.2062796641109894,1.3101308909759404,"['GABRB3', 'RAB3A', 'SHC3', 'BAD', 'RPS6', 'RACK1', 'IKBKG', 'SQSTM1', 'EIF2S1', 'HRAS']",0.9997174930961258,0,0,10
124,Endothelin Pathways WP2197,0.34905446973158427,1.5009036144578314,1.5797420217239497,"['CNN1', 'RIIAD1', 'CALM2']",0.9997174930961258,0,0,3
125,Signaling of Hepatocyte Growth Factor Receptor WP313,0.34905446973158427,1.5009036144578314,1.5797420217239497,"['MAP4K1', 'PAK1', 'HRAS']",0.9997174930961258,0,0,3
126,Sterol regulatory element-binding proteins (SREBP) signaling WP1982,0.35251482810112145,1.3168103448275863,1.3729888874149618,"['IDI1', 'SQLE', 'HMGCS1', 'DBI', 'FDFT1']",0.9997174930961258,0,0,5
127,TNF-alpha signaling pathway WP231,0.36308621601331,1.2291306850892343,1.2452506888409727,"['BAD', 'BAX', 'KRAS', 'IKBKG', 'TXN', 'HRAS', 'SKP1']",0.9997174930961258,0,0,7
128,Apoptosis WP254,0.36731843741737213,1.2509706643658327,1.2528798085448116,"['IRF3', 'BAD', 'TNFRSF10B', 'CYCS', 'BAX', 'IKBKG']",0.9997174930961258,0,0,6
129,Nucleotide metabolism WP404,0.3681539333408521,1.667383204356549,1.6661395551687042,"['NME2', 'OAZ1']",0.9997174930961258,0,0,2
130,Serotonin and anxiety WP3947,0.3681539333408521,1.667383204356549,1.6661395551687042,"['POMC', 'CRH']",0.9997174930961258,0,0,2
131,STING pathway in Kawasaki-like disease and COVID-19 WP4961,0.3681539333408521,1.667383204356549,1.6661395551687042,"['IRF3', 'IKBKG']",0.9997174930961258,0,0,2
132,BDNF-TrkB Signaling WP3676,0.37476991978311264,1.429309073026801,1.4027853681986189,"['HOMER1', 'KRAS', 'HRAS']",0.9997174930961258,0,0,3
133,MAPK Cascade WP422,0.37476991978311264,1.429309073026801,1.4027853681986189,"['RRAS', 'KRAS', 'HRAS']",0.9997174930961258,0,0,3
134,Parkinson's disease pathway WP2371,0.37476991978311264,1.429309073026801,1.4027853681986189,"['PINK1', 'CYCS', 'PARK7']",0.9997174930961258,0,0,3
135,Type 2 papillary renal cell carcinoma WP4241,0.37476991978311264,1.429309073026801,1.4027853681986189,"['ELOB', 'ELOC', 'RBX1']",0.9997174930961258,0,0,3
136,Acetylcholine Synthesis WP528,0.3791993328593235,2.5006443298969074,2.424857972213476,['PDHA1'],0.9997174930961258,0,0,1
137,Alanine and aspartate metabolism WP106,0.3791993328593235,2.5006443298969074,2.424857972213476,['GOT1'],0.9997174930961258,0,0,1
138,"Degradation pathway of sphingolipids, including diseases WP4153",0.3791993328593235,2.5006443298969074,2.424857972213476,['GM2A'],0.9997174930961258,0,0,1
139,Glial Cell Differentiation WP2276,0.3791993328593235,2.5006443298969074,2.424857972213476,['GAP43'],0.9997174930961258,0,0,1
140,let-7 inhibition of ES cell reprogramming WP3299,0.3791993328593235,2.5006443298969074,2.424857972213476,['TRIM71'],0.9997174930961258,0,0,1
141,Molybdenum cofactor (Moco) biosynthesis WP4507,0.3791993328593235,2.5006443298969074,2.424857972213476,['MOCS2'],0.9997174930961258,0,0,1
142,Cell cycle WP179,0.3808785847994942,1.1698422684581855,1.129219062505163,"['CDKN2D', 'CCNB1', 'CCND1', 'YWHAQ', 'GADD45A', 'SKP1', 'RBX1', 'ANAPC11', 'YWHAH']",0.9997174930961258,0,0,9
143,Thyroid stimulating hormone (TSH) signaling pathway WP2032,0.3898343932563068,1.2507543103448275,1.1782521638309469,"['APEX1', 'RPS6', 'GNA12', 'HRAS', 'MYL12B']",0.9997174930961258,0,0,5
144,Novel intracellular components of RIG-I-like receptor (RLR) pathway WP3865,0.395450896500858,1.2909894140201716,1.1976878726617826,"['TKFC', 'IRF3', 'PIN1', 'IKBKG']",0.9997174930961258,0,0,4
145,PPAR signaling pathway WP3942,0.395450896500858,1.2909894140201716,1.1976878726617826,"['FABP3', 'FABP5', 'FABP6', 'DBI']",0.9997174930961258,0,0,4
146,Neurodegeneration with brain iron accumulation (NBIA) subtypes pathway WP4577,0.400274042097412,1.3642231262713191,1.2490906904096417,"['MAP1LC3A', 'ATG101', 'FTL']",0.9997174930961258,0,0,3
147,Renin-angiotensin-aldosterone system (RAAS) WP4756,0.400274042097412,1.3642231262713191,1.2490906904096417,"['STAR', 'CALM3', 'CALM2']",0.9997174930961258,0,0,3
148,IL-7 signaling pathway WP205,0.40169574657511464,1.5389906739863748,1.4036523361867728,"['CCND1', 'BAD']",0.9997174930961258,0,0,2
149,miRNA regulation of p53 pathway in prostate cancer WP3982,0.40169574657511464,1.5389906739863748,1.4036523361867728,"['TNFRSF10B', 'BAX']",0.9997174930961258,0,0,2
150,IL-18 signaling pathway WP4754,0.4026776965538726,1.0969395662696568,0.9977968491199218,"['NRN1', 'IMP3', 'BAD', 'COX17', 'NDUFC1', 'BPGM', 'RND2', 'ICAM1', 'PTMS', 'NACA', 'TMSB4X', 'CYCS', 'BAX', 'RPS11', 'AARS', 'ITM2C']",0.9997174930961258,0,0,16
151,22q11.2 copy number variation syndrome WP4657,0.4091277099399575,1.1673719055843408,1.0433128678892545,"['RANBP1', 'MRPL40', 'DGCR6L', 'EMC10', 'RAN', 'RBX1', 'PAK4']",0.9997174930961258,0,0,7
152,ATM Signaling Pathway WP2516,0.4254767293338623,1.304796827059792,1.115007634109262,"['CCNB1', 'GADD45A', 'IKBKG']",0.9997174930961258,0,0,3
153,FBXL10 enhancement of MAP/ERK signaling in diffuse large B-cell lymphoma WP4553,0.43436736465298353,1.4289399336690825,1.1915424842206348,"['H3F3B', 'H2AFZ']",0.9997174930961258,0,0,2
154,Photodynamic therapy-induced NF-kB survival signaling WP3617,0.43436736465298353,1.4289399336690825,1.1915424842206348,"['CCND1', 'ICAM1']",0.9997174930961258,0,0,2
155,TLR4 Signaling and Tolerance WP3851,0.43436736465298353,1.4289399336690825,1.1915424842206348,"['IRF3', 'IKBKG']",0.9997174930961258,0,0,2
156,Canonical NF-KB pathway WP4562,0.43567091571370337,2.000343642611684,1.6620217238771333,['IKBKG'],0.9997174930961258,0,0,1
157,Role of Altered Glycolysation of MUC1 in Tumour Microenvironment WP4480,0.43567091571370337,2.000343642611684,1.6620217238771333,['IKBKG'],0.9997174930961258,0,0,1
158,Acute viral myocarditis WP4298,0.44541809151792094,1.1631916599839616,0.9407218406021702,"['ENDOG', 'CCND1', 'RAC3', 'CYCS', 'BAX']",0.9997174930961258,0,0,5
159,Glycogen Synthesis and Degradation WP500,0.4502983338804519,1.2503227194492255,0.997563669711706,"['UGP2', 'CALM3', 'CALM2']",0.9997174930961258,0,0,3
160,Nucleotide-binding Oligomerization Domain (NOD) pathway WP1433,0.4502983338804519,1.2503227194492255,0.997563669711706,"['NDUFA13', 'COPS6', 'IKBKG']",0.9997174930961258,0,0,3
161,Regulation of Microtubule Cytoskeleton WP2038,0.4502983338804519,1.2503227194492255,0.997563669711706,"['PAK1', 'PARD6A', 'CFL2']",0.9997174930961258,0,0,3
162,Genotoxicity pathway WP4286,0.4584985694843208,1.1767745858033136,0.9176465947058785,"['RPS27', 'GADD45A', 'BLOC1S2', 'TRIAP1']",0.9997174930961258,0,0,4
163,Prader-Willi and Angelman Syndrome WP3998,0.4584985694843208,1.1767745858033136,0.9176465947058785,"['GABRB3', 'POMC', 'CCND1', 'FEZ1']",0.9997174930961258,0,0,4
164,miRNAs involvement in the immune response in sepsis WP4329,0.4660496758146156,1.3335626253940958,1.0181257894525588,"['IKBKG', 'ICAM1']",0.9997174930961258,0,0,2
165,"Relationship between inflammation, COX-2 and EGFR WP4483",0.4660496758146156,1.3335626253940958,1.0181257894525588,"['KRAS', 'HRAS']",0.9997174930961258,0,0,2
166,Striated Muscle Contraction Pathway WP383,0.4660496758146156,1.3335626253940958,1.0181257894525588,"['TPM3', 'ACTG1']",0.9997174930961258,0,0,2
167,TGF-beta Signaling Pathway WP366,0.4740710554255884,1.071706623826001,0.799919747657174,"['MAP4K1', 'KLF6', 'PARD6A', 'CCND1', 'CITED1', 'SUMO1', 'STRAP', 'SKP1', 'RBX1']",0.9997174930961258,0,0,9
168,G13 Signaling Pathway WP524,0.474669207968442,1.2002065404475044,0.8943184471464637,"['CFL2', 'ARHGDIB', 'CALM2']",0.9997174930961258,0,0,3
169,Histone Modifications WP2369,0.474669207968442,1.2002065404475044,0.8943184471464637,"['SET', 'H3F3B', 'SETD9']",0.9997174930961258,0,0,3
170,Oxidative Damage WP3941,0.474669207968442,1.2002065404475044,0.8943184471464637,"['BAD', 'GADD45A', 'CYCS']",0.9997174930961258,0,0,3
171,PDGF Pathway WP2526,0.474669207968442,1.2002065404475044,0.8943184471464637,"['PAK1', 'ARFIP2', 'HRAS']",0.9997174930961258,0,0,3
172,Exercise-induced Circadian Regulation WP410,0.47903702875813553,1.143054017472622,0.8412619012778103,"['IDI1', 'UGP2', 'SUMO1', 'STBD1']",0.9997174930961258,0,0,4
173,G1 to S cell cycle control WP45,0.4817773948479612,1.111302681992337,0.8115544635359945,"['CDKN2D', 'CCNB1', 'CCND1', 'GADD45A', 'RPA2']",0.9997174930961258,0,0,5
174,Small cell lung cancer WP4658,0.4851463795827712,1.0771090740002658,0.7790779694774522,"['CCND1', 'GADD45A', 'CYCS', 'BAX', 'IKBKG', 'CKS1B', 'SKP1']",0.9997174930961258,0,0,7
175,ACE Inhibitor Pathway WP554,0.48700951747546994,1.6668098510882017,1.1992223721596051,['MAS1'],0.9997174930961258,0,0,1
176,Cholesterol Biosynthesis with Skeletal Dysplasias WP4804,0.48700951747546994,1.6668098510882017,1.1992223721596051,['NSDHL'],0.9997174930961258,0,0,1
177,Classical pathway of steroidogenesis with glucocorticoid and mineralocorticoid metabolism WP4523,0.48700951747546994,1.6668098510882017,1.1992223721596051,['STAR'],0.9997174930961258,0,0,1
178,Cytosine methylation WP3585,0.48700951747546994,1.6668098510882017,1.1992223721596051,['TDG'],0.9997174930961258,0,0,1
179,Insulin signaling in adipocytes (diabetic condition) WP3635,0.48700951747546994,1.6668098510882017,1.1992223721596051,['RPS6'],0.9997174930961258,0,0,1
180,Insulin signaling in adipocytes (normal condition) WP3634,0.48700951747546994,1.6668098510882017,1.1992223721596051,['RPS6'],0.9997174930961258,0,0,1
181,Interactome of polycomb repressive complex 2 (PRC2)  WP2916,0.48700951747546994,1.6668098510882017,1.1992223721596051,['ELL'],0.9997174930961258,0,0,1
182,Interleukin-1 Induced Activation of NF-kappa-B WP3656,0.48700951747546994,1.6668098510882017,1.1992223721596051,['SQSTM1'],0.9997174930961258,0,0,1
183,Iron metabolism in placenta WP2007,0.48700951747546994,1.6668098510882017,1.1992223721596051,['FTH1'],0.9997174930961258,0,0,1
184,Mammary gland development pathway - Involution (Stage 4 of 4) WP2815,0.48700951747546994,1.6668098510882017,1.1992223721596051,['BAX'],0.9997174930961258,0,0,1
185,Methionine metabolism leading to sulfur amino acids and related disorders WP4292,0.48700951747546994,1.6668098510882017,1.1992223721596051,['AHCY'],0.9997174930961258,0,0,1
186,MicroRNA for Targeting Cancer Growth and Vascularization in Glioblastoma WP3593,0.48700951747546994,1.6668098510882017,1.1992223721596051,['VEGFB'],0.9997174930961258,0,0,1
187,NLR Proteins WP288,0.48700951747546994,1.6668098510882017,1.1992223721596051,['IKBKG'],0.9997174930961258,0,0,1
188,Purine metabolism WP4792,0.48700951747546994,1.6668098510882017,1.1992223721596051,['APRT'],0.9997174930961258,0,0,1
189,Role of Osx and miRNAs in tooth development WP3971,0.48700951747546994,1.6668098510882017,1.1992223721596051,['NOTCH4'],0.9997174930961258,0,0,1
190,Supression of HMGB1 mediated inflammation by THBD WP4479,0.48700951747546994,1.6668098510882017,1.1992223721596051,['IKBKG'],0.9997174930961258,0,0,1
191,Thiamine metabolic pathways WP4297,0.48700951747546994,1.6668098510882017,1.1992223721596051,['PDHA1'],0.9997174930961258,0,0,1
192,Intraflagellar transport proteins binding to dynein WP4532,0.49665238548966434,1.2501074806534824,0.8749063759040459,"['IFT22', 'DYNLL1']",0.9997174930961258,0,0,2
193,Sleep regulation WP3591,0.49852917765728144,1.1539454521382233,0.8032535366917468,"['AHCY', 'STAR', 'CRH']",0.9997174930961258,0,0,3
194,Amino Acid metabolism WP3925,0.49965078008580893,1.0870502248875562,0.7542453029453375,"['LDHA', 'PDHA1', 'GOT1', 'ODC1', 'DLD']",0.9997174930961258,0,0,5
195,Envelope proteins and their potential roles in EDMD physiopathology WP4535,0.5218269727102018,1.1111111111111112,0.7226880177240196,"['BANF1', 'KRAS', 'HRAS']",0.9997174930961258,0,0,3
196,Kisspeptin/kisspeptin receptor system in the ovary WP4871,0.5218269727102018,1.1111111111111112,0.7226880177240196,"['STAR', 'KRAS', 'HRAS']",0.9997174930961258,0,0,3
197,Autophagy WP4923,0.5261097682571082,1.1764705882352942,0.755582827196055,"['MAP1LC3B', 'ATG101']",0.9997174930961258,0,0,2
198,Fatty acid beta-oxidation WP143,0.5261097682571082,1.1764705882352942,0.755582827196055,"['TPI1', 'DLD']",0.9997174930961258,0,0,2
199,Toll-like Receptor Signaling related to MyD88 WP3858,0.5261097682571082,1.1764705882352942,0.755582827196055,"['IRF3', 'IKBKG']",0.9997174930961258,0,0,2
200,White fat cell differentiation WP4149,0.5261097682571082,1.1764705882352942,0.755582827196055,"['IRF3', 'DDIT3']",0.9997174930961258,0,0,2
201,Cell-type Dependent Selectivity of CCK2R Signaling WP3679,0.5336813350553501,1.4285714285714286,0.8970805271160949,['CCK'],0.9997174930961258,0,0,1
202,Dopamine metabolism WP2436,0.5336813350553501,1.4285714285714286,0.8970805271160949,['SOD1'],0.9997174930961258,0,0,1
203,Host-pathogen interaction of human coronaviruses - autophagy WP4863,0.5336813350553501,1.4285714285714286,0.8970805271160949,['MAP1LC3A'],0.9997174930961258,0,0,1
204,Mammary gland development pathway - Puberty (Stage 2 of 4) WP2814,0.5336813350553501,1.4285714285714286,0.8970805271160949,['CCND1'],0.9997174930961258,0,0,1
205,Somitogenesis in the context of spondylocostal dysostosis WP4785,0.5336813350553501,1.4285714285714286,0.8970805271160949,['DLL3'],0.9997174930961258,0,0,1
206,Proximal tubule transport WP4917,0.5386438341486054,1.0525409130060293,0.6512078170938892,"['ATP6V1G1', 'ATP6V1E1', 'ATP6V1D', 'ATP6V1F']",0.9997174930961258,0,0,4
207,Vitamin B12 metabolism WP1533,0.5445196294471799,1.07133636587165,0.6512131886452258,"['SERPINA3', 'ICAM1', 'SOD1']",0.9997174930961258,0,0,3
208,Apoptosis Modulation and Signaling WP1772,0.5472960413019405,1.0167736651993975,0.6128759992476082,"['ENDOG', 'AIFM2', 'BAD', 'TNFRSF10B', 'CYCS', 'BAX']",0.9997174930961258,0,0,6
209,16p11.2 proximal deletion syndrome WP4949,0.5517209840390973,1.0202322308233638,0.6067451913248383,"['TMEM219', 'SEZ6L2', 'CCT7', 'CDIPT', 'CCT4']",0.9997174930961258,0,0,5
210,Head and Neck Squamous Cell Carcinoma WP4674,0.5517209840390973,1.0202322308233638,0.6067451913248383,"['CCND1', 'SESN1', 'RPS6', 'KRAS', 'HRAS']",0.9997174930961258,0,0,5
211,Fluoropyrimidine Activity WP1601,0.5543769523824382,1.1110155727524602,0.6553996455419472,"['TDG', 'GGH']",0.9997174930961258,0,0,2
212,Gastric Cancer Network 2 WP2363,0.5543769523824382,1.1110155727524602,0.6553996455419472,"['S100A6', 'COL9A3']",0.9997174930961258,0,0,2
213,Host-pathogen interaction of human coronaviruses - interferon induction WP4880,0.5543769523824382,1.1110155727524602,0.6553996455419472,"['IRF3', 'IKBKG']",0.9997174930961258,0,0,2
214,Nanoparticle-mediated activation of receptor signaling WP2643,0.5543769523824382,1.1110155727524602,0.6553996455419472,"['KRAS', 'HRAS']",0.9997174930961258,0,0,2
215,Type II interferon signaling (IFNG) WP619,0.5543769523824382,1.1110155727524602,0.6553996455419472,"['HLA-B', 'ICAM1']",0.9997174930961258,0,0,2
216,Breast cancer pathway WP4262,0.5639159969012747,0.9886687706756911,0.5663588857468548,"['SHC3', 'CCND1', 'GADD45A', 'NOTCH4', 'BAX', 'KRAS', 'HRAS', 'SKP1', 'DLL3']",0.9997174930961258,0,0,9
217,Interleukin-11 Signaling Pathway WP2332,0.566571881008663,1.0343047065107722,0.5876415847053755,"['RPS6', 'HRAS', 'ICAM1']",0.9997174930961258,0,0,3
218,Cells and molecules involved in local acute inflammatory response  WP4493,0.5761102567800168,1.2498926116838487,0.689261053274599,['ICAM1'],0.9997174930961258,0,0,1
219,H19 action Rb-E2F1 signaling and CDK-Beta-catenin activity WP3969,0.5761102567800168,1.2498926116838487,0.689261053274599,['CCND1'],0.9997174930961258,0,0,1
220,Serotonin and anxiety-related events WP3944,0.5761102567800168,1.2498926116838487,0.689261053274599,['CRH'],0.9997174930961258,0,0,1
221,SREBF and miR33 in cholesterol and lipid homeostasis WP2011,0.5761102567800168,1.2498926116838487,0.689261053274599,['HMGCS1'],0.9997174930961258,0,0,1
222,Sulfation Biotransformation Reaction WP692,0.5761102567800168,1.2498926116838487,0.689261053274599,['SULT4A1'],0.9997174930961258,0,0,1
223,Transcription co-factors SKI and SKIL protein partners WP4533,0.5761102567800168,1.2498926116838487,0.689261053274599,['LATS1'],0.9997174930961258,0,0,1
224,Intracellular trafficking proteins involved in CMT neuropathy WP4856,0.5814266763556103,1.0524505588993982,0.5707127949691562,"['RAB3A', 'NEFL']",0.9997174930961258,0,0,2
225,Lipid Metabolism Pathway WP3965,0.5814266763556103,1.0524505588993982,0.5707127949691562,"['PDHA1', 'PRKAR1A']",0.9997174930961258,0,0,2
226,IL-3 signaling pathway WP286,0.5879555468554779,0.9997418244406197,0.5309668164719147,"['YWHAQ', 'BAD', 'HRAS']",0.9997174930961258,0,0,3
227,DNA damage response (only ATM dependent) WP710,0.592583095678061,0.9673244454340505,0.5061662229990804,"['CCND1', 'BAD', 'RAC3', 'BAX', 'KRAS', 'HRAS']",0.9997174930961258,0,0,6
228,Pathways in clear cell renal cell carcinoma WP4018,0.592583095678061,0.9673244454340505,0.5061662229990804,"['LDHA', 'TPI1', 'PGBD5', 'PGK1', 'SQSTM1', 'PFKM']",0.9997174930961258,0,0,6
229,Integrin-mediated Cell Adhesion WP185,0.6071384800810223,0.951887916512593,0.4749905239248451,"['PAK1', 'SHC3', 'RAC3', 'ITGAE', 'HRAS', 'PAK4']",0.9997174930961258,0,0,6
230,Overview of leukocyte-intrinsic Hippo pathway functions WP4542,0.6072464620597167,0.9997420464316423,0.4986918647468783,"['LATS1', 'YWHAQ']",0.9997174930961258,0,0,2
231,Notch Signaling WP268,0.6086489301324952,0.9674088057298318,0.48033167417549416,"['NOTCH4', 'DTX3', 'DLL3']",0.9997174930961258,0,0,3
232,Biomarkers for urea cycle disorders WP4583,0.6146816989565903,1.1109201985490644,0.5406301009661255,['GOT1'],0.9997174930961258,0,0,1
233,Glutathione metabolism WP100,0.6146816989565903,1.1109201985490644,0.5406301009661255,['GPX4'],0.9997174930961258,0,0,1
234,Nanoparticle triggered autophagic cell death WP2509,0.6146816989565903,1.1109201985490644,0.5406301009661255,['MAP1LC3A'],0.9997174930961258,0,0,1
235,Nanoparticle triggered regulated necrosis WP2513,0.6146816989565903,1.1109201985490644,0.5406301009661255,['FTL'],0.9997174930961258,0,0,1
236,Osteoclast Signaling WP12,0.6146816989565903,1.1109201985490644,0.5406301009661255,['ATP6V1G1'],0.9997174930961258,0,0,1
237,Regulation of sister chromatid separation at the metaphase-anaphase transition WP4240,0.6146816989565903,1.1109201985490644,0.5406301009661255,['ANAPC11'],0.9997174930961258,0,0,1
238,SARS coronavirus and innate immunity WP4912,0.6146816989565903,1.1109201985490644,0.5406301009661255,['IRF3'],0.9997174930961258,0,0,1
239,Kit receptor signaling pathway WP304,0.6286362302932367,0.9370966006884681,0.4350026033323699,"['BAD', 'RPS6', 'HRAS']",0.9997174930961258,0,0,3
240,Synaptic signaling pathways associated with autism spectrum disorder WP4539,0.6286362302932367,0.9370966006884681,0.4350026033323699,"['HOMER1', 'KRAS', 'HRAS']",0.9997174930961258,0,0,3
241,Hepatitis B infection WP4666,0.6307709715654306,0.9295089545938775,0.4283292925251304,"['YWHAQ', 'IRF3', 'BAD', 'CYCS', 'BAX', 'KRAS', 'IKBKG', 'HRAS']",0.9997174930961258,0,0,8
242,Aryl Hydrocarbon Receptor Pathway WP2873,0.6318361555499233,0.952053392294149,0.4371116717715582,"['AIP', 'BAX']",0.9997174930961258,0,0,2
243,IL-2 signaling pathway WP49,0.6318361555499233,0.952053392294149,0.4371116717715582,"['RPS6', 'HRAS']",0.9997174930961258,0,0,2
244,Complement system WP2806,0.6320965446784659,0.92536717752235,0.4244780798924065,"['FCGR3A', 'RPS19', 'CD59', 'TXN', 'ICAM1']",0.9997174930961258,0,0,5
245,Prolactin Signaling Pathway WP2037,0.6470733189209998,0.9084639498432602,0.39545042329992763,"['PTPN1', 'PAK1', 'RPS6', 'PPIB', 'HRAS']",0.9997174930961258,0,0,5
246,ERK Pathway in Huntington's Disease WP3853,0.6497460948603427,0.9997422680412371,0.4310624884768459,['HRAS'],0.9997174930961258,0,0,1
247,FGF23 signaling in hypophosphatemic rickets and related disorders WP4790,0.6497460948603427,0.9997422680412371,0.4310624884768459,['CCND1'],0.9997174930961258,0,0,1
248,Genes targeted by miRNAs in adipocytes WP1992,0.6497460948603427,0.9997422680412371,0.4310624884768459,['TMSB4X'],0.9997174930961258,0,0,1
249,Hedgehog Signaling Pathway Netpath WP47,0.6497460948603427,0.9997422680412371,0.4310624884768459,['SAP18'],0.9997174930961258,0,0,1
250,NOTCH1 regulation of endothelial cell calcification WP3413,0.6497460948603427,0.9997422680412371,0.4310624884768459,['DLL3'],0.9997174930961258,0,0,1
251,Platelet-mediated interactions with vascular and circulating cells WP4462,0.6497460948603427,0.9997422680412371,0.4310624884768459,['ICAM1'],0.9997174930961258,0,0,1
252,Purine metabolism and related disorders WP4224,0.6497460948603427,0.9997422680412371,0.4310624884768459,['APRT'],0.9997174930961258,0,0,1
253,Transcriptional cascade regulating adipogenesis WP4211,0.6497460948603427,0.9997422680412371,0.4310624884768459,['DDIT3'],0.9997174930961258,0,0,1
254,Extracellular vesicle-mediated signaling in recipient cells WP2870,0.6552057926509461,0.9087000703509732,0.38420375601814544,"['KRAS', 'HRAS']",0.9997174930961258,0,0,2
255,Fibrin Complement Receptor 3 Signaling Pathway WP4136,0.6552057926509461,0.9087000703509732,0.38420375601814544,"['IRF3', 'IKBKG']",0.9997174930961258,0,0,2
256,Host-pathogen interaction of human coronaviruses - MAPK signaling WP4877,0.6552057926509461,0.9087000703509732,0.38420375601814544,"['IFITM3', 'DDIT3']",0.9997174930961258,0,0,2
257,p38 MAPK Signaling Pathway WP400,0.6552057926509461,0.9087000703509732,0.38420375601814544,"['DDIT3', 'HRAS']",0.9997174930961258,0,0,2
258,DNA IR-double strand breaks and cellular response via ATM WP3959,0.666455485303686,0.8818214032600992,0.35782719122604006,"['LATS1', 'NABP2', 'BAX']",0.9997174930961258,0,0,3
259,Interferon type I signaling pathways WP585,0.666455485303686,0.8818214032600992,0.35782719122604006,"['PTPRC', 'RPS6', 'RACK1']",0.9997174930961258,0,0,3
260,IL-5 signaling pathway WP127,0.6773737495646287,0.8691166024898127,0.33854880757690453,"['RPS6', 'KRAS']",0.9997174930961258,0,0,2
261,Insulin Signaling WP481,0.6792148490791104,0.8900099352495803,0.34427166877498716,"['MAP4K1', 'CAP1', 'PTPN1', 'XBP1', 'SHC3', 'STX4', 'HRAS', 'PFKM', 'VAMP2']",0.9997174930961258,0,0,9
262,Circadian rhythm related genes WP3594,0.6813246725051916,0.8916975881261595,0.3421589241975332,"['RAI1', 'AHCY', 'HOMER1', 'STAR', 'CAVIN3', 'CRH', 'RPS27A', 'UBA52', 'SKP1', 'CIART']",0.9997174930961258,0,0,10
263,Airway smooth muscle cell contraction WP4962,0.6816220675629048,0.9087785067166511,0.3483165605058375,['CALM2'],0.9997174930961258,0,0,1
264,NAD Metabolism in Oncogene-Induced Senescence and Mitochondrial Dysfunction-Associated Senescence WP5046,0.6816220675629048,0.9087785067166511,0.3483165605058375,['GOT1'],0.9997174930961258,0,0,1
265,Type I interferon induction and signaling during SARS-CoV-2 infection WP4868,0.6816220675629048,0.9087785067166511,0.3483165605058375,['IRF3'],0.9997174930961258,0,0,1
266,"Non-genomic actions of 1,25 dihydroxyvitamin D3 WP4341",0.6842803469137154,0.8565527415785591,0.3249654729877993,"['IFI27L2', 'KRAS', 'HRAS']",0.9997174930961258,0,0,3
267,Neural Crest Cell Migration during Development WP4564,0.6983651459836377,0.8328317569504156,0.2989975784869558,"['PAK1', 'PAK4']",0.9997174930961258,0,0,2
268,MFAP5 effect on permeability and motility of endothelial cells via cytoskeleton rearrangement WP4560,0.7105993150927091,0.832975372279496,0.2845831698703775,['LPP'],0.9997174930961258,0,0,1
269,miRNAs involved in DNA damage response WP1545,0.7105993150927091,0.832975372279496,0.2845831698703775,['CCND1'],0.9997174930961258,0,0,1
270,Overview of nanoparticle effects WP3287,0.7105993150927091,0.832975372279496,0.2845831698703775,['BAX'],0.9997174930961258,0,0,1
271,Vitamin D in inflammatory diseases WP4482,0.7105993150927091,0.832975372279496,0.2845831698703775,['IKBKG'],0.9997174930961258,0,0,1
272,Cardiac Hypertrophic Response WP2795,0.7177719750598867,0.8101130390287017,0.26863619264348937,"['MAP4K1', 'IKBKG', 'CALM2']",0.9997174930961258,0,0,3
273,Common Pathways Underlying Drug Addiction WP2636,0.7182104685201166,0.7994496990541703,0.26461195144345234,"['CALM2', 'ACTG1']",0.9997174930961258,0,0,2
274,RANKL/RANK signaling pathway WP2018,0.7334530764232439,0.7887263339070568,0.24449858206463113,"['IKBKG', 'SQSTM1', 'ICAM1']",0.9997174930961258,0,0,3
275,Fragile X Syndrome  WP4549,0.7355116992612567,0.8207831503303509,0.2521354177067261,"['HOMER1', 'PRKAR1A', 'CLTC', 'AP2S1', 'KRAS', 'AP2M1']",0.9997174930961258,0,0,6
276,Spinal Cord Injury WP2431,0.7355116992612567,0.8207831503303509,0.2521354177067261,"['BCAN', 'GAP43', 'CCND1', 'GADD45A', 'APEX1', 'ICAM1']",0.9997174930961258,0,0,6
277,Retinoblastoma gene in cancer WP2446,0.7359329333942307,0.7991042204995693,0.24501836942386002,"['CCNB1', 'CCND1', 'H2AFZ', 'RPA2']",0.9997174930961258,0,0,4
278,T-cell receptor (TCR) signaling pathway WP69,0.7359329333942307,0.7991042204995693,0.24501836942386002,"['MAP4K1', 'PAK1', 'IKBKG', 'HRAS']",0.9997174930961258,0,0,4
279,Apoptosis Modulation by HSP70 WP384,0.7369412343699969,0.7688342585249802,0.23468444797004706,['CYCS'],0.9997174930961258,0,0,1
280,Cannabinoid receptor signaling WP3869,0.7369412343699969,0.7688342585249802,0.23468444797004706,['PRKAR1A'],0.9997174930961258,0,0,1
281,Glycerolipids and Glycerophospholipids WP4722,0.7369412343699969,0.7688342585249802,0.23468444797004706,['CDIPT'],0.9997174930961258,0,0,1
282,IL1 and megakaryocytes in obesity WP2865,0.7369412343699969,0.7688342585249802,0.23468444797004706,['ICAM1'],0.9997174930961258,0,0,1
283,Mammary gland development pathway - Embryonic development (Stage 1 of 4) WP2813,0.7369412343699969,0.7688342585249802,0.23468444797004706,['CCND1'],0.9997174930961258,0,0,1
284,MAPK pathway in congenital thyroid cancer WP4928,0.7369412343699969,0.7688342585249802,0.23468444797004706,['KRAS'],0.9997174930961258,0,0,1
285,T-Cell Receptor and Co-stimulatory Signaling WP2583,0.7369412343699969,0.7688342585249802,0.23468444797004706,['CALM2'],0.9997174930961258,0,0,1
286,Neural Crest Cell Migration in Cancer WP4565,0.7369443887836151,0.7686354917653284,0.23462048491674958,"['PAK1', 'PAK4']",0.9997174930961258,0,0,2
287,Photodynamic therapy-induced AP-1 survival signaling. WP3611,0.7369443887836151,0.7686354917653284,0.23462048491674958,"['CCND1', 'BAX']",0.9997174930961258,0,0,2
288,Mesodermal commitment pathway WP2857,0.7426460344317951,0.8222493142334654,0.24464856497882362,"['TRIM71', 'LATS1', 'CCND1', 'PRKAR1A', 'SESN1', 'NABP2', 'RPL38']",0.9997174930961258,0,0,7
289,Rett syndrome causing genes WP4312,0.7546047515713192,0.740103818349734,0.20838450046767673,"['IMPDH2', 'GPS2']",0.9997174930961258,0,0,2
290,Gastrin signaling pathway WP4659,0.7572151315458984,0.7987575496117343,0.22214076579648648,"['PAK1', 'CCND1', 'BAD', 'RPS6', 'KRAS', 'HRAS']",0.9997174930961258,0,0,6
291,Ebstein-Barr virus LMP1 signaling WP262,0.7608873069832806,0.7138561610211095,0.19507548563048432,['IKBKG'],0.9997174930961258,0,0,1
292,EPO Receptor Signaling WP581,0.7608873069832806,0.7138561610211095,0.19507548563048432,['PTPRC'],0.9997174930961258,0,0,1
293,Glycerophospholipid Biosynthetic Pathway WP2533,0.7608873069832806,0.7138561610211095,0.19507548563048432,['CDIPT'],0.9997174930961258,0,0,1
294,Pregnane X receptor pathway WP2876,0.7608873069832806,0.7138561610211095,0.19507548563048432,['PSMC5'],0.9997174930961258,0,0,1
295,Regulation of apoptosis by parathyroid hormone-related protein WP3872,0.7608873069832806,0.7138561610211095,0.19507548563048432,['BAX'],0.9997174930961258,0,0,1
296,Wnt/beta-catenin signaling pathway in leukemia WP3658,0.7608873069832806,0.7138561610211095,0.19507548563048432,['CCND1'],0.9997174930961258,0,0,1
297,One-carbon metabolism and related pathways WP3940,0.771231712186079,0.7136101216066822,0.1853719436811158,"['GPX4', 'SOD1']",0.9997174930961258,0,0,2
298,Ebola Virus Pathway on Host WP4217,0.7775842936095791,0.7778761359434353,0.195685029087403,"['PAK1', 'IRF3', 'CLTC', 'HLA-B', 'EIF2S1', 'ACTG1']",0.9997174930961258,0,0,6
299,Follicle Stimulating Hormone (FSH) signaling pathway WP2035,0.7826552691942771,0.6662084765177548,0.1632630140151892,['RPS6'],0.9997174930961258,0,0,1
300,Urea cycle and metabolism of amino groups WP497,0.7826552691942771,0.6662084765177548,0.1632630140151892,['ODC1'],0.9997174930961258,0,0,1
301,SARS-CoV-2 innate immunity evasion and cell-specific immune response WP5039,0.8015533218778824,0.6659214674691889,0.14730434681105584,"['IRF3', 'NUP98']",0.9997174930961258,0,0,2
302,Endochondral Ossification with Skeletal Dysplasias WP4808,0.8017131999946899,0.696713765360445,0.153976766623391,"['HMGCS1', 'SLC38A2', 'CALM2']",0.9997174930961258,0,0,3
303,Endochondral Ossification WP474,0.8017131999946899,0.696713765360445,0.153976766623391,"['HMGCS1', 'SLC38A2', 'CALM2']",0.9997174930961258,0,0,3
304,Oncostatin M Signaling Pathway WP2374,0.8017131999946899,0.696713765360445,0.153976766623391,"['RPS6', 'KRAS', 'HRAS']",0.9997174930961258,0,0,3
305,EGF/EGFR signaling pathway WP437,0.8020667662824827,0.7749536380495254,0.1709264285096488,"['MAP4K1', 'NDUFA13', 'PAK1', 'AP2S1', 'NEDD8', 'KRAS', 'HRAS', 'AP2M1']",0.9997174930961258,0,0,8
306,NRF2-ARE regulation WP4357,0.8024430846420296,0.6245167525773195,0.1374526081340334,['RBX1'],0.9997174930961258,0,0,1
307,PDGFR-beta pathway WP3972,0.8024430846420296,0.6245167525773195,0.1374526081340334,['HRAS'],0.9997174930961258,0,0,1
308,Physiological and pathological hypertrophy of the heart WP1528,0.8024430846420296,0.6245167525773195,0.1374526081340334,['CALM2'],0.9997174930961258,0,0,1
309,Urea cycle and associated pathways WP4595,0.8024430846420296,0.6245167525773195,0.1374526081340334,['GOT1'],0.9997174930961258,0,0,1
310,NRF2 pathway WP2884,0.8056847419389126,0.74851164797239,0.16172548658288946,"['FTH1', 'MGST3', 'PRDX1', 'TXN', 'SQSTM1', 'FTL']",0.9997174930961258,0,0,6
311,Netrin-UNC5B signaling pathway WP4747,0.8153337992032185,0.6443846559232241,0.1315560763921585,"['DAPK1', 'ICAM1']",0.9997174930961258,0,0,2
312,Thyroid hormones production and their peripheral downstream signaling effects WP4746,0.8175096799056748,0.7005455067470572,0.14115469032988617,"['POMC', 'BAD', 'RPS6', 'HRAS']",0.9997174930961258,0,0,4
313,Effect of progerin on genes involved in Hutchinson-Gilford progeria syndrome WP4320,0.8204307384335819,0.5877299373357591,0.11632690972537738,['H3F3B'],0.9997174930961258,0,0,1
314,MTHFR deficiency WP4288,0.8204307384335819,0.5877299373357591,0.11632690972537738,['CYCS'],0.9997174930961258,0,0,1
315,Focal Adhesion WP306,0.823123681943753,0.7730460753716568,0.15047249692166667,"['PAK1', 'SHC3', 'CCND1', 'BAD', 'VEGFB', 'RAC3', 'HRAS', 'MYL12B', 'PAK4', 'ACTG1']",0.9997174930961258,0,0,10
316,Thermogenesis WP4321,0.8272792605113064,0.6884077341174374,0.13053102951965845,"['RPS6', 'KRAS', 'HRAS', 'ACTG1']",0.9997174930961258,0,0,4
317,Integrated Cancer Pathway WP1971,0.8282515790988759,0.6241938950988822,0.11762205597221144,"['BAD', 'BAX']",0.9997174930961258,0,0,2
318,Chemokine signaling pathway WP3929,0.8309414785032714,0.7212698940715407,0.1335762340902425,"['GNG3', 'PAK1', 'SHC3', 'KRAS', 'IKBKG', 'HRAS']",0.9997174930961258,0,0,6
319,Calcium Regulation in the Cardiac Cell WP536,0.8309916307231447,0.7350604490500864,0.13608582456784798,"['RGS4', 'GNG3', 'YWHAQ', 'PRKAR1A', 'CALM3', 'CALM2', 'YWHAH']",0.9997174930961258,0,0,7
320,B Cell Receptor Signaling Pathway WP23,0.8366107574006123,0.6766814114074658,0.1207175017447215,"['MAP4K1', 'PTPRC', 'IKBKG', 'HRAS']",0.9997174930961258,0,0,4
321,Ethanol effects on histone modifications WP3996,0.8367818689334207,0.5550305460099274,0.09890192149329981,['AHCY'],0.9997174930961258,0,0,1
322,One-carbon metabolism WP241,0.8367818689334207,0.5550305460099274,0.09890192149329981,['AHCY'],0.9997174930961258,0,0,1
323,Trans-sulfuration and one-carbon metabolism WP2525,0.8367818689334207,0.5550305460099274,0.09890192149329981,['AHCY'],0.9997174930961258,0,0,1
324,Tumor suppressor activity of SMARCB1 WP4204,0.8367818689334207,0.5550305460099274,0.09890192149329981,['H3F3B'],0.9997174930961258,0,0,1
325,Type I collagen synthesis in the context of Osteogenesis imperfecta WP4786,0.8367818689334207,0.5550305460099274,0.09890192149329981,['PPIB'],0.9997174930961258,0,0,1
326,7-oxo-C and 7beta-HC pathways WP5064,0.8516452510987729,0.5257731958762887,0.08443139949777193,['THEM5'],0.9997174930961258,0,0,1
327,Estrogen signaling pathway WP712,0.8516452510987729,0.5257731958762887,0.08443139949777193,['IKBKG'],0.9997174930961258,0,0,1
328,Resistin as a regulator of inflammation WP4481,0.8516452510987729,0.5257731958762887,0.08443139949777193,['IKBKG'],0.9997174930961258,0,0,1
329,Epithelial to mesenchymal transition in colorectal cancer WP4239,0.8604479354591942,0.6878700425455951,0.1033883601740241,"['PAK1', 'NOTCH4', 'STRAP', 'KRAS', 'HRAS', 'DLL3']",0.9997174930961258,0,0,6
330,Heart Development WP1591,0.8651561452772378,0.49944158075601375,0.07234175239669591,['VEGFB'],0.9997174930961258,0,0,1
331,mBDNF and proBDNF regulation of GABA neurotransmission WP4829,0.8651561452772378,0.49944158075601375,0.07234175239669591,['GABRB3'],0.9997174930961258,0,0,1
332,Oxidative Stress WP408,0.8651561452772378,0.49944158075601375,0.07234175239669591,['SOD1'],0.9997174930961258,0,0,1
333,The influence of laminopathies on Wnt signaling WP4844,0.8651561452772378,0.49944158075601375,0.07234175239669591,['CCND1'],0.9997174930961258,0,0,1
334,Metapathway biotransformation Phase I and II WP702,0.8671220514210758,0.6799945093732842,0.09695058280055943,"['AKR7A2', 'AKR7A3', 'GPX4', 'GSTO1', 'MGST3', 'SULT4A1']",0.9997174930961258,0,0,6
335,Angiopoietin Like Protein 8 Regulatory Pathway WP3915,0.8708097330177358,0.65625,0.09078022575909805,"['MAP4K1', 'CAP1', 'PTPN1', 'SHC3', 'HRAS']",0.9997174930961258,0,0,5
336,IL-1 signaling pathway WP195,0.8721405699818322,0.5546479411483711,0.07587842520354302,"['IKBKG', 'SQSTM1']",0.9997174930961258,0,0,2
337,Cell migration and invasion through p75NTR WP4561,0.8774375243517745,0.4756177385043364,0.062186792676010925,['PAK1'],0.9997174930961258,0,0,1
338,IL17 signaling pathway WP2112,0.8774375243517745,0.4756177385043364,0.062186792676010925,['IKBKG'],0.9997174930961258,0,0,1
339,Zinc homeostasis WP3529,0.8774375243517745,0.4756177385043364,0.062186792676010925,['MT3'],0.9997174930961258,0,0,1
340,Glioblastoma signaling pathways WP2261,0.8876880331206306,0.5756818482722097,0.0685838062006655,"['CCND1', 'KRAS', 'HRAS']",0.9997174930961258,0,0,3
341,Hair Follicle Development: Organogenesis - Part 2 of 3 WP2839,0.8886011885521081,0.4539597000937207,0.05361570522913663,['CCND1'],0.9997174930961258,0,0,1
342,Target Of Rapamycin (TOR) Signaling WP1471,0.8886011885521081,0.4539597000937207,0.05361570522913663,['IDI1'],0.9997174930961258,0,0,1
343,3q29 copy number variation syndrome WP4906,0.8980081161900008,0.5118504310249796,0.05506291033752947,"['PIGM', 'DYNLL1']",0.9997174930961258,0,0,2
344,Cardiac Progenitor Differentiation WP2406,0.8987487803507638,0.4341849693709846,0.0463499953171052,['MESP1'],0.9997174930961258,0,0,1
345,Initiation of transcription and translation elongation at the HIV-1 LTR WP3414,0.8987487803507638,0.4341849693709846,0.0463499953171052,['SUPT4H1'],0.9997174930961258,0,0,1
346,Melatonin metabolism and effects WP3298,0.8987487803507638,0.4341849693709846,0.0463499953171052,['CALM2'],0.9997174930961258,0,0,1
347,Regucalcin in proximal tubule epithelial kidney cells WP4838,0.8987487803507638,0.4341849693709846,0.0463499953171052,['BAX'],0.9997174930961258,0,0,1
348,Vitamin D-sensitive calcium signaling in depression WP4698,0.8987487803507638,0.4341849693709846,0.0463499953171052,['GPX4'],0.9997174930961258,0,0,1
349,Pathways affected in adenoid cystic carcinoma WP3651,0.9054865782936936,0.4990111779879622,0.04954323905503967,"['BRD1', 'HRAS']",0.9997174930961258,0,0,2
350,Phosphodiesterases in neuronal function WP4222,0.9054865782936936,0.4990111779879622,0.04954323905503967,"['PDE1C', 'PDE6G']",0.9997174930961258,0,0,2
351,Endoderm differentiation WP2853,0.9067473823495336,0.6079163162321278,0.05950977178468201,"['TRIM71', 'SESN1', 'TCEAL2', 'NABP2', 'NME1']",0.9997174930961258,0,0,5
352,Corticotropin-releasing hormone signaling pathway WP2355,0.9078739833149475,0.5441401971522454,0.05259098404182964,"['POMC', 'STAR', 'CRH']",0.9997174930961258,0,0,3
353,Microglia Pathogen Phagocytosis Pathway WP3937,0.9079727060156186,0.4160581328751432,0.040166651682900484,['RAC3'],0.9997174930961258,0,0,1
354,Disruption of postsynaptic signaling by CNV WP4875,0.9163569747349597,0.3993814432989691,0.034885681444055766,['HOMER1'],0.9997174930961258,0,0,1
355,Hedgehog Signaling Pathway WP4249,0.9163569747349597,0.3993814432989691,0.034885681444055766,['CCND1'],0.9997174930961258,0,0,1
356,Neovascularisation processes WP4331,0.9163569747349597,0.3993814432989691,0.034885681444055766,['NOTCH4'],0.9997174930961258,0,0,1
357,Oxysterols derived from cholesterol WP4545,0.9163569747349597,0.3993814432989691,0.034885681444055766,['THEM5'],0.9997174930961258,0,0,1
358,AGE/RAGE pathway WP2324,0.9189293909032373,0.4751668509192155,0.040173452828779016,"['CYCS', 'SOD1']",0.9997174930961258,0,0,2
359,Neural Crest Differentiation WP2064,0.9194421777263013,0.5249569707401033,0.04409014978247728,"['PRTG', 'NOTCH4', 'DLL3']",0.9997174930961258,0,0,3
360,ncRNAs involved in Wnt signaling in hepatocellular carcinoma WP4336,0.9305576996860686,0.45349018994762763,0.032638231112380116,"['SFRP2', 'CCND1']",0.9997174930961258,0,0,2
361,Alpha 6 Beta 4 signaling pathway WP244,0.9309050970930832,0.36973399516354843,0.026472193669221114,['HRAS'],0.9997174930961258,0,0,1
362,Pre-implantation embryo WP3527,0.9309050970930832,0.36973399516354843,0.026472193669221114,['DDIT3'],0.9997174930961258,0,0,1
363,Adipogenesis WP236,0.9327795453447687,0.538817887655097,0.037494392670892204,"['KLF6', 'GADD45A', 'DDIT3', 'GTF3A']",0.9997174930961258,0,0,4
364,Factors and pathways affecting insulin-like growth factor (IGF1)-Akt signaling WP3850,0.9372015053191919,0.35649852724594994,0.023121412918393983,['MAP1LC3A'],0.9997174930961258,0,0,1
365,IL-6 signaling pathway WP364,0.9372015053191919,0.35649852724594994,0.023121412918393983,['BAD'],0.9997174930961258,0,0,1
366,Wnt signaling WP428,0.9427865694264703,0.482413525068014,0.028421563330081806,"['SFRP2', 'CCND1', 'PRICKLE2']",0.9997174930961258,0,0,3
367,Prostaglandin Synthesis and Regulation WP98,0.9429245693138188,0.3441758502192203,0.02022686698663181,['S100A6'],0.9997174930961258,0,0,1
368,Regulation of toll-like receptor signaling pathway WP1449,0.9443246064877338,0.5176907502488898,0.029656074666459458,"['CUEDC2', 'IRF3', 'IKBKG', 'SQSTM1']",0.9997174930961258,0,0,4
369,ATM Signaling Network in Development and Disease  WP3878,0.9481264562730458,0.3326746849942726,0.01772071316346824,['IKBKG'],0.9997174930961258,0,0,1
370,Thymic Stromal LymphoPoietin (TSLP) Signaling Pathway WP2203,0.9481264562730458,0.3326746849942726,0.01772071316346824,['RPS6'],0.9997174930961258,0,0,1
371,Nuclear Receptors Meta-Pathway WP2882,0.9489331686234297,0.6397072982861545,0.033531477193122355,"['PSMC5', 'CCND1', 'FTH1', 'MGST3', 'PRDX1', 'AIP', 'BAX', 'DBI', 'TXN', 'SQSTM1', 'FTL']",0.9997174930961258,0,0,11
372,MAPK Signaling Pathway WP382,0.950384576239809,0.625554738762286,0.03183357936219287,"['MAP4K1', 'PAK1', 'RRAS', 'GADD45A', 'DDIT3', 'GNA12', 'RAC3', 'KRAS', 'IKBKG', 'HRAS']",0.9997174930961258,0,0,10
373,LncRNA involvement in canonical Wnt signaling and colorectal cancer WP4258,0.9566839628690295,0.39886500429922617,0.017662611679144187,"['SFRP2', 'CCND1']",0.9997174930961258,0,0,2
374,Development of ureteric collection system WP5053,0.9571520840751454,0.31182882302405496,0.013655914229087004,['CCND1'],0.9997174930961258,0,0,1
375,Hepatitis C and Hepatocellular Carcinoma WP3646,0.9571520840751454,0.31182882302405496,0.013655914229087004,['CCND1'],0.9997174930961258,0,0,1
376,Primary focal segmental glomerulosclerosis (FSGS) WP2572,0.9600003271607727,0.39101040244128604,0.0159616912524422,"['MYO1E', 'YWHAQ']",0.9997174930961258,0,0,2
377,Nephrotic syndrome WP4758,0.96105812940761,0.3023534312194106,0.012009594205426345,['MYO1E'],0.9997174930961258,0,0,1
378,Phosphoinositides metabolism WP4971,0.96105812940761,0.3023534312194106,0.012009594205426345,['PIP4P1'],0.9997174930961258,0,0,1
379,DNA IR-damage and cellular response via ATR WP4016,0.9630723615977498,0.38345790065480523,0.014428266189112611,"['RPA2', 'IKBKG']",0.9997174930961258,0,0,2
380,TGF-beta Receptor Signaling WP560,0.9646083544261571,0.2934354154032747,0.010573390706253051,['HRAS'],0.9997174930961258,0,0,1
381,Sudden Infant Death Syndrome (SIDS) Susceptibility Pathways WP706,0.965538892221962,0.5027864855451062,0.01763216695954606,"['YWHAQ', 'PRKAR1A', 'SLC25A4', 'VAMP2', 'YWHAH']",0.9997174930961258,0,0,5
382,Complement and Coagulation Cascades WP558,0.9678351470376482,0.285027000490918,0.00931853276468058,['CLTC'],0.9997174930961258,0,0,1
383,IL-4 signaling pathway WP395,0.9678351470376482,0.285027000490918,0.00931853276468058,['BAD'],0.9997174930961258,0,0,1
384,Wnt Signaling Pathway WP363,0.9678351470376482,0.285027000490918,0.00931853276468058,['CCND1'],0.9997174930961258,0,0,1
385,MicroRNAs in cardiomyocyte hypertrophy WP1544,0.968550239807425,0.36919206394700804,0.011797504214622143,"['IKBKG', 'CALM2']",0.9997174930961258,0,0,2
386,Translation inhibitors in chronically activated PDGFRA cells WP4566,0.9707679493269062,0.2770857197403589,0.008220529362314214,['RPS6'],0.9997174930961258,0,0,1
387,Toll-like Receptor Signaling Pathway WP75,0.9709868811334713,0.36244821386695847,0.010671316824628227,"['IRF3', 'IKBKG']",0.9997174930961258,0,0,2
388,TGF-beta receptor signaling in skeletal dysplasias WP4816,0.9734335255242448,0.269573697408749,0.007258471422901107,['HRAS'],0.9997174930961258,0,0,1
389,Vitamin D Receptor Pathway WP2877,0.9792196330120071,0.432722915028274,0.0090868858267998,"['CDKN2D', 'CCND1', 'GADD45A', 'S100A6']",0.9997174930961258,0,0,4
390,Allograft Rejection WP2328,0.9800593263694454,0.24929123711340206,0.005021266985538272,['HLA-B'],0.9997174930961258,0,0,1
391,MECP2 and Associated Rett Syndrome WP3584,0.9800593263694454,0.24929123711340206,0.005021266985538272,['RPS6'],0.9997174930961258,0,0,1
392,Pathways Regulating Hippo Signaling WP4540,0.9860936552591043,0.31123710232158214,0.004358546901989618,"['LATS1', 'PRKAR1A']",0.9997174930961258,0,0,2
393,Focal Adhesion-PI3K-Akt-mTOR-signaling pathway WP3932,0.9883999663196937,0.5277240490006447,0.006157399210227555,"['GNG3', 'RAB14', 'CAB39L', 'BAD', 'RPS6', 'VEGFB', 'KRAS', 'IKBKG', 'ITGAE', 'HRAS']",0.9997174930961258,0,0,10
394,Genes related to primary cilium development (based on CRISPR) WP4536,0.9891540269695424,0.29722411160021045,0.0032412941405089413,"['TRAF3IP1', 'DYNLL1']",0.9997174930961258,0,0,2
395,Ectoderm Differentiation WP2858,0.9892541338847471,0.35117950794775743,0.003794150398806054,"['KCNK10', 'CELSR2', 'LY6E']",0.9997174930961258,0,0,3
396,AMP-activated protein kinase (AMPK) signaling WP1403,0.9897924390405947,0.21203480295386415,0.002175480337168691,['CCNB1'],0.9997174930961258,0,0,1
397,Osteoblast differentiation WP4787,0.9928560074430889,0.27646412534632653,0.0019821463334754735,"['NOTCH4', 'DLL3']",0.9997174930961258,0,0,2
398,Regulatory circuits of the STAT3 signaling pathway WP4538,0.9930387577060978,0.19533724142577993,0.0013645448599083937,['PTPRC'],0.9997174930961258,0,0,1
399,Arrhythmogenic Right Ventricular Cardiomyopathy WP2118,0.994251459552279,0.18793360565389353,0.0010834610857778984,['ACTG1'],0.9997174930961258,0,0,1
400,"GPCRs, Other WP117",0.994251459552279,0.18793360565389353,0.0010834610857778984,['CELSR2'],0.9997174930961258,0,0,1
401,Joubert Syndrome WP4656,0.9964378443103313,0.17165837184500532,0.000612565521717061,['PDE6G'],0.9997174930961258,0,0,1
402,Wnt signaling pathway and pluripotency WP399,0.9973269835283954,0.16317390569545379,0.00043675051872256714,['CCND1'],0.9997174930961258,0,0,1
403,PI3K-Akt signaling pathway WP4172,0.9975292260673827,0.443345555957238,0.0010967621270806624,"['GNG3', 'CCND1', 'BAD', 'RPS6', 'VEGFB', 'COL9A3', 'KRAS', 'IKBKG', 'HRAS']",0.9997174930961258,0,0,9
404,"GPCRs, Class A Rhodopsin-like WP455",0.9978880927897287,0.28109472932159907,0.0005942737322263516,"['MAS1', 'GPR22', 'APLNR']",0.9997174930961258,0,0,3
405,ESC Pluripotency Pathways WP3931,0.9991519767597409,0.1362095749187968,0.00011555788989323059,['HRAS'],0.9997174930961258,0,0,1
406,Ciliopathies WP4803,0.9997174930961258,0.2269579955591176,6.412625911691799e-05,"['TRAF3IP1', 'NEK2', 'CCNQ']",0.9997174930961258,0,0,3
